Offered by: Nemours Children's
Locations: Delaware Valley and Jacksonville, Orlando and Pensacola in Florida
Intergroup Trial for Children or Adolescents With B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients
To see if using rituximab in combination with the DA-EPOCH chemotherapy will result in improved treatment outcome for children with PMLBL.
6 months to < 18 yrs of age.
Length of study is 5 months. In addition to standard NHL care, other tests performed include immune system recovery blood tests and PET scans.
Trial Name: Intergroup Trial for Children or Adolescents with B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients
COG#: ANHL1131
(800) 354-5690 Email UsLearn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.